Table S3 from Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer Neil H. Segal , Andrea Cercek , Geoffrey Ku , Abraham J. Wu , Andreas Rimner , Danny N. Khalil , Diane Reidy-Lagunes , John Cuaron , T. Jonathan Yang , Martin R. Weiser , Paul B. Romesser , Zsofia K. Stadler , Anna M. Varghese , Karuna Ganesh , Rona Yaeger , Louise C. Connell , David Faleck , Ghassan K. Abou-Alfa , Kathleen C. Mcauliffe , Pamela Vaiskauskas , Mark L. Solter , Martinique Ogle , Matthew J. Adamow , Aliya Holland , Pallavi Vedantam , Phillip Wong , Taha Merghoub , Efsevia Vakiani , Travis J. Hollmann , Krishna Juluru , Joanne F. Chou , Marinela Capanu , Joseph Erinjeri , Stephen Solomon , Yoshiya Yamada , Nancy Kemeny , Christopher H. Crane , Leonard B. Saltz crossref（2023）
摘要
Gene mutations in responder patients
更多 查看译文
AI 理解论文
溯源树
样例
